Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental Outcomes

Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental Outcomes

Recent large-scale cohort studies suggest that previously observed links between prenatal exposure to acid-suppressants or antipsychotics and neurodevelopmental disorders are largely due to familial confounding. Conversely, active maternal eating disorders remain a significant risk factor, highlighting the critical role of maternal health optimization.
Beyond Picky Eating: Large-Scale Study Reveals the Genetic Architecture and Developmental Impact of ARFI Phenotypes

Beyond Picky Eating: Large-Scale Study Reveals the Genetic Architecture and Developmental Impact of ARFI Phenotypes

This large-scale study of 35,751 children characterizes ARFI phenotypes, revealing a 6.3% clinical prevalence and significant genetic heritability. Findings link ARFI to the ADCY3 locus and long-term neurodevelopmental difficulties, emphasizing the need for early identification and broad support interventions.